- Long-term stability of human parvovirus B19 neutralizing antibody titer trends in donor-derived pooled plasma and plasma-derived immunoglobulin product lots in Japan. [Journal Article]Transfusion. 2026 Oct 28. [Online ahead of print]T
- CONCLUSIONS: In Japan, the neutralizing properties of donor-derived pooled plasma remained stable and functionally comparable to those reported overseas. Stable neutralizing titers, alongside B19 antigen screening, ensure effective protection against B19 transmission. Continuous monitoring of DNA levels and neutralizing titers remains critical for the timely detection of unpredictable epidemiological changes.
- Publisher Full Text (DOI)
- Shelf-life of cord blood red cell concentrates: Comparison of two additive solutions. [Journal Article]Transfusion. 2026 Oct 28. [Online ahead of print]T
- CONCLUSIONS: CB-RBC maintained acceptable in vitro quality over 28 days of storage in DEHP-free bags. PAGGSM was associated with distinct temporal patterns in selected metabolic, ionic, and red cell indices, warranting further investigation as an alternative additive solution for CB-RBCs.
- Publisher Full Text (DOI)
- When blood is needed but not available: A proposal for measuring patient-level blood unavailability. [Journal Article]Transfusion. 2026 Oct 27. [Online ahead of print]T
- Publisher Full Text (DOI)
- Prophylactic oral calcium-vitamin D3-magnesium supplementation reduced citrate-related reactions during peripheral blood stem cell collection in healthy donors: A randomized controlled trial. [Journal Article]Transfusion. 2026 Oct 27. [Online ahead of print]T
- CONCLUSIONS: Prophylactic oral calcium-vitamin D3-magnesium supplementation markedly reduced citrate-related reactions during PBSC collection in healthy donors and may represent a practical approach to improving donor safety.
- Publisher Full Text (DOI)
- Identification and structural analysis of a novel RHD allele comprising c.520G>A and c.953G>C in a weak D phenotype individual. [Journal Article]Transfusion. 2026 Oct 27. [Online ahead of print]T
- Publisher Full Text (DOI)
- Development of a systematic drug screening method for cord blood donation for transfusion to extremely preterm neonates. [Journal Article]Transfusion. 2026 Oct 27. [Online ahead of print]T
- CONCLUSIONS: A large proportion of drugs currently accepted for blood donation are unsuitable or cannot be reliably assessed for CB-RBC transfusion in extremely preterm neonates. These findings highlight critical knowledge gaps in neonatal pharmacology, underscoring the need for a CB-specific, precautionary, and dynamically updated CB-donor drug screening questionnaire.
- Publisher Full Text (DOI)
- No transfusion-transmitted cytomegalovirus infections in neonates receiving leukoreduced-only blood products. [Journal Article]Transfusion. 2026 Oct 26. [Online ahead of print]T
- CONCLUSIONS: There were no demonstrable cases of TT-CMV in 481 preterm, VLBW infants who received leukoreduced-only blood products. In five cases of postnatal CMV, alternative sources of exposure were present. dLR-only is a safe TT-CMV mitigation strategy and is more logistically manageable than alternatives.
- Publisher Full Text (DOI)
- Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient-derived anti-E and anti-K alloantibodies in vitro. [Journal Article]Transfusion. 2026 Oct 26. [Online ahead of print]T
- CONCLUSIONS: These findings support a functional contribution of FcγRI and FcγRIII to alloantibody-mediated RBC phagocytosis in this in vitro macrophage model, while suggesting a limited role for FcγRIIA under these experimental conditions.
- Publisher Full Text (DOI)
- A PIGG congenital disorder of glycosylation (PIGG-CDG) variant associated with an Emm- red blood cell phenotype in a pediatric patient. [Case Reports]Transfusion. 2026 Oct 26. [Online ahead of print]T
- CONCLUSIONS: This case expands the number of PIGG variants associated with the Emm- phenotype and underscores the importance of integrating the growing number of genomic diagnostic findings with transfusion medicine evaluation to guide safe transfusion management.
- Publisher Full Text (DOI)
- Alpha-gal sensitization and the transfusion medicine diagnostic gap: A single-center study with multi-institutional TriNetX validation. [Journal Article]Transfusion. 2026 Oct 23. [Online ahead of print]T
- CONCLUSIONS: Most α-Gal-sensitized patients lack documented ABO type, representing a possible gap in TRAGS preparedness. Allergy-Transfusion Medicine collaboration when α-Gal sensitization is identified may facilitate preemptive ABO typing and transfusion risk stratification.
- Publisher Full Text (DOI)
- Infection following therapeutic plasma exchange: A large-scale descriptive cohort study. [Journal Article]Transfusion. 2026 Oct 22. [Online ahead of print]T
- CONCLUSIONS: These hypothesis generating findings in a large cohort of over 22,000 patients covering various indications across multiple care settings are roughly consistent with prior literature and indicate further studies with comparator groups are needed to clarify whether TPE independently increases infection risk.
- Publisher Full Text (DOI)
- A novel RHD allele with a 520-bp deletion identified in a D-negative Chinese Han male donor. [Journal Article]Transfusion. 2026 Oct 22. [Online ahead of print]T
- Publisher Full Text (DOI)
- ABO genotyping in transfusion medicine and transplantation: Evolution, current state, and future directions. [Review]Transfusion. 2026 Oct 22. [Online ahead of print]T
- Publisher Full Text (DOI)
- In response: Hemoglobin concentration or transfusion phase? Interpreting noninvasive hemoglobin agreement in very preterm infants. [Letter]Transfusion. 2026 Oct 22. [Online ahead of print]T
- Publisher Full Text (DOI)
- Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation. [Journal Article]Transfusion. 2026 Oct 20. [Online ahead of print]T
- CONCLUSIONS: Newly detectable HBV antibodies were common after HCT without virologic evidence of infection, suggesting passive antibody transfer from cellular blood components, particularly platelets.
- Publisher Full Text (DOI)